Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Patients should be prepared to discuss medical history, current medications, previous treatments, wellness goals, and recent lab work if available
GH can affect glucose FDA Status AOD-9604 Not approved (GRAS for the oral form) Tesamorelin FDA-approved (Egrifta, 2010) Human Evidence AOD-9604 Modest weight-loss results in trials Tesamorelin 2 Phase 3 RCTs, 816 patients Fat Targeted AOD-9604 General adipose, including abdominal Tesamorelin Visceral (deep belly) fat specifically Best-For AOD-9604 Fat support without shifting hormones Tesamorelin Deep visceral fat
PMC 4513480
These effects are typically short-lived and well tolerated when used as directed
The refrigerant is either reclaimed for reuse or properly destroyed never released into the atmosphere
